De Novo device
B.R.A.H.M.S PCT sensitive KRYPTOR
Brahms GmbH · Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens (PMT, Class II) · First FDA decision Feb 20, 2016, newest Feb 20, 2016Sepsis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
1
Naming "B.R.A.H.M.S PCT sensitive"
MAUDE reports
0
Brand "B.R.A.H.M.S PCT sensitive", since 2015
PubMed studies
0
Mentioning "B.R.A.H.M.S PCT sensitive"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing B.R.A.H.M.S PCT sensitive KRYPTOR
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "B.R.A.H.M.S PCT sensitive", any status and sponsor, newest update first.
- Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of InfectionTerminated
Brahms AGNot on our public-company list
NCT00407147 · 11 participants · Start Jul 2008 · Primary completion Jun 2009
Device: Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor · For: Infection; Bacterial Infection; Sepsis
Sites: St Louis, Missouri; Camden, New Jersey; Providence, Rhode Island
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "B.R.A.H.M.S PCT sensitive", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PMT
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "B.R.A.H.M.S PCT sensitive"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PMT.
- VITROS BRAHMS PCT Reagent Pack and CalibratorsOrtho Clinical Diagnostics · 510(k) 2020
- Atellica IM BRAHMS Procalcitonin (PCT)Siemens Healthcare Diagnostics, Inc. · 510(k) 2018
- Vidas B.r.a.h.m.s. Pct (Pct)bioMerieux, Inc. · 510(k) 2016
- Elecys BRAHMS PCT, Elecys BRAHMS PCT CalCheck 5Roche Diagnostics · 510(k) 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.